Market cap
$1.8bn
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
In Q2 2026, biologics represented 55% of our worldwide sales. Our business opportunities include the following: • growing our direct sales force in North America, Europe, and APAC, including replacing distributors with our direct sales personnel; • increasing the average selling prices of our devices; • introducing our products into new territories upon receipt of regulatory approvals or registrations; • acquiring complementary products and transitioning distributor sales to LeMaitre; • updating existing products and introducing new products through research and development; and • consolidating product manufacturing into our Burlington, Massachusetts facilities. …LEMAITRE VASCULAR INC, 10-Q, period ended 2026-06-30, filed 2026-08-05